期刊
EUROPEAN JOURNAL OF ENDOCRINOLOGY
卷 185, 期 4, 页码 D11-D20出版社
BIOSCIENTIFICA LTD
DOI: 10.1530/EJE-21-0344
关键词
-
Non-functioning pituitary adenomas often require surgery due to their large and invasive nature, leading to common postsurgical tumor remnants. Active surveillance is the typical follow-up strategy, but the high prevalence of residual tumor growth may require repeat surgery or radiation therapy.
Non-functioning pituitary adenomas (NFPA) usually present with symptoms of mass effect. Thus, the first-line treatment generally consists of transsphenoidal surgery. Since these tumors are usually large and invasive, postsurgical tumor remnants are common. Active surveillance is the follow-up strategy adopted by most pituitary centers, although the prevalence of residual tumor growth may reach 50% in 5-10 years, often leading to repeat surgery, radiation therapy, or both. NFPA remain the only pituitary tumor type for which no medical therapy has been approved. In this debate, we consider the evidence in favor and against using cabergoline to treat progressing NFPA.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据